Awarded Over $1.1 Million to Scale its New Technology that Eliminates a Cancer-causing Chemical in Water — Microvi
Summary
Hayward, CA (November 15, 2022) Microvi announced today that it has been awarded over $1.1M in funding from the National Institute of Health (NIH) to scale-up its newly developed technology to eliminate chromium, a cancer-causing chemical, in drinking water.Chromium in drinking water threatens the health of millions of people due to its link to cancers and reproductive effects. To address this challenge, the current Federal standard for total chromium in drinking water (100 parts per billion (ppb)) is under review. This new technology was successfully shown to reduce hexavalent chromium in water to very low levels (less than 5 ppb), meeting both current and potential future regulatory limits. Consor continue to be at the forefront of working with companies like Microvi to deliver transformative projects for the industry.Microvis MNE technology has been successfully applied in a number of applications across the water and wastewater sectors. Additionally, along with the 2021 commissioning of its first commercial side-stream treatment system in the Pacific U.S., the advantages of the Microvi MNE Technology are currently being demonstrated for total nitrogen removal at Linda County Water District Wastewater Treatment Plant.Microvi is a transformative biology company based in the San Francisco Bay Area that delivers next-generation biotechnologies for the water, wastewater, bio-based chemicals, biofuels and biopharma industries.